Nalmefene, a reducing alcohol consumption drug, enhanced oxLDL uptake in macrophages and aggravates atherosclerotic plaque formation in apolipoprotein E knockout mice.
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.